CD4 and cancer: Indeed, the efficacy of cyclophosphamide is partly due to intestinal bacteria, against which the host becomes immunized during the treatment, accumulating anti-commensal effector pTh17 and memory Th1 CD4+ T cells, which are necessary for the anti-cancer effect [177,178].